10-Q Filing

AGIOS PHARMACEUTICALS, INC. CIK: 1439222 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001439222-21-000064`
Period End Date	20210630
Filing Date	20210729
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	agio-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 74 Cash Flow Statement 80 Stockholders Equity 36 Comprehensive Income 14

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$127.44M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$969.12M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$445.49M	USD	Point-in-time
Marketable securities	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$703.86M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$8.13M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$21.44M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$15.89M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$47.86M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	70.40M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	69.29M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	69.29M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.70B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	59.91M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$636.68M	USD	Point-in-time
Marketable securities	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent`	$97.61M	USD	Point-in-time
Treasury shares (in shares)	`TreasuryStockShares`	0.00	shares	Point-in-time
Marketable securities	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent`	$61.31M	USD	Point-in-time
Treasury shares (in shares)	`TreasuryStockShares`	10.49M	shares	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$84.66M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$79.90M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$30.82M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.06M	USD	Point-in-time
Financing lease assets	`FinanceLeaseRightOfUseAsset`	$590.00K	USD	Point-in-time
Financing lease assets	`FinanceLeaseRightOfUseAsset`	$871.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$2.90M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Non-current assets of discontinued operations	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$2.60M	USD	Point-in-time
Non-current assets of discontinued operations	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	-	USD	Point-in-time
Total assets	`Assets`	$1.87B	USD	Point-in-time
Total assets	`Assets`	$852.95M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.65M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$17.72M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$36.05M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$30.80M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$7.09M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$8.93M	USD	Point-in-time
Financing lease liabilities	`FinanceLeaseLiabilityCurrent`	$317.00K	USD	Point-in-time
Financing lease liabilities	`FinanceLeaseLiabilityCurrent`	$839.00K	USD	Point-in-time
Income tax payable	`TaxesPayableCurrent`	$7.17M	USD	Point-in-time
Income tax payable	`TaxesPayableCurrent`	-	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$38.46M	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$94.39M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$60.65M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$91.97M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$97.46M	USD	Point-in-time
Financing lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$167.00K	USD	Point-in-time
Financing lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$331.00K	USD	Point-in-time
Non-current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	-	USD	Point-in-time
Non-current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$261.27M	USD	Point-in-time
Total liabilities	`Liabilities`	$152.79M	USD	Point-in-time
Total liabilities	`Liabilities`	$453.45M	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at June 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at June 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 70,404,782 shares issued and 59,910,814 outstanding at June 30, 2021, and 69,293,920 shares issued and outstanding at December 31, 2020	`CommonStockValue`	$70.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 70,404,782 shares issued and 59,910,814 outstanding at June 30, 2021, and 69,293,920 shares issued and outstanding at December 31, 2020	`CommonStockValue`	$69.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.24B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.31B	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-144.00K	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$105.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.84B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-55.37M	USD	Point-in-time
Treasury stock, at cost (10,493,968 shares at June 30, 2021 and no shares at December 31, 2020)	`TreasuryStockValue`	$529.05M	USD	Point-in-time
Treasury stock, at cost (10,493,968 shares at June 30, 2021 and no shares at December 31, 2020)	`TreasuryStockValue`	-	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.72B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$558.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.30B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$640.53M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$625.30M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$399.50M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.87B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$852.95M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	69.29M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	59.91M	shares	Point-in-time

Income Statement 74 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$54.09M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$109.44M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$119.67M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$62.01M	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$60.85M	USD	2 Qtrs
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$29.21M	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$29.18M	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$62.77M	USD	2 Qtrs
Total cost and expenses	`CostsAndExpenses`	$182.44M	USD	2 Qtrs
Total cost and expenses	`CostsAndExpenses`	$170.29M	USD	2 Qtrs
Total cost and expenses	`CostsAndExpenses`	$91.22M	USD	1 Quarter
Total cost and expenses	`CostsAndExpenses`	$83.26M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-83.26M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-91.22M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-182.44M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-170.29M	USD	2 Qtrs
Gain on sale of oncology business	`ContingentGainOnDispositionOfBusinessRecognized`	$2.00M	USD	2 Qtrs
Gain on sale of oncology business	`ContingentGainOnDispositionOfBusinessRecognized`	-	USD	2 Qtrs
Gain on sale of oncology business	`ContingentGainOnDispositionOfBusinessRecognized`	-	USD	1 Quarter
Gain on sale of oncology business	`ContingentGainOnDispositionOfBusinessRecognized`	$2.00M	USD	1 Quarter
Interest (expense) income, net	`InterestRevenueExpenseNet`	$-92.00K	USD	1 Quarter
Interest (expense) income, net	`InterestRevenueExpenseNet`	$4.71M	USD	2 Qtrs
Interest (expense) income, net	`InterestRevenueExpenseNet`	$248.00K	USD	2 Qtrs
Interest (expense) income, net	`InterestRevenueExpenseNet`	$1.77M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	-	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$6.52M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$6.52M	USD	2 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-173.67M	USD	2 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-165.59M	USD	2 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-82.79M	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-81.50M	USD	1 Quarter
Net income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-8.98M	USD	1 Quarter
Net income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-3.43M	USD	1 Quarter
Net income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$34.85M	USD	2 Qtrs
Net income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$1.96B	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-90.48M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-86.22M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$1.79B	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$1.87B	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-130.73M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-40.26M	USD	1 Quarter
Net loss from continuing operations per share - basic (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-2.41	USD	2 Qtrs
Net loss from continuing operations per share - basic (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.36	USD	1 Quarter
Net loss from continuing operations per share - basic (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-2.66	USD	2 Qtrs
Net loss from continuing operations per share - basic (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.18	USD	1 Quarter
Net loss from continuing operations per share - diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.36	USD	1 Quarter
Net loss from continuing operations per share - diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-2.41	USD	2 Qtrs
Net loss from continuing operations per share - diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-2.66	USD	2 Qtrs
Net loss from continuing operations per share - diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.18	USD	1 Quarter
Net income (loss) from discontinued operations per share - basic (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.51	USD	2 Qtrs
Net income (loss) from discontinued operations per share - basic (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$30.05	USD	2 Qtrs
Net income (loss) from discontinued operations per share - basic (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.13	USD	1 Quarter
Net income (loss) from discontinued operations per share - basic (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.06	USD	1 Quarter
Net income (loss) from discontinued operations per share - diluted (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.51	USD	2 Qtrs
Net income (loss) from discontinued operations per share - diluted (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.06	USD	1 Quarter
Net income (loss) from discontinued operations per share - diluted (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.13	USD	1 Quarter
Net income (loss) from discontinued operations per share - diluted (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$30.05	USD	2 Qtrs
Net income (loss) per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.31	USD	1 Quarter
Net income (loss) per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.90	USD	2 Qtrs
Net income (loss) per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.41	USD	1 Quarter
Net income (loss) per share - basic (in usd per share)	`EarningsPerShareBasic`	$27.39	USD	2 Qtrs
Net income (loss) per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.41	USD	1 Quarter
Net income (loss) per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.90	USD	2 Qtrs
Net income (loss) per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.31	USD	1 Quarter
Net income (loss) per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$27.39	USD	2 Qtrs
Weighted-average number of common shares used in computing net loss per share from continuing operations, net income (loss) per share from discontinued operations and net income (loss) per share basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	61.07M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net income (loss) per share from discontinued operations and net income (loss) per share basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	65.28M	shares	2 Qtrs
Weighted-average number of common shares used in computing net loss per share from continuing operations, net income (loss) per share from discontinued operations and net income (loss) per share basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	68.96M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net income (loss) per share from discontinued operations and net income (loss) per share basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	68.78M	shares	2 Qtrs
Weighted-average number of common shares used in computing net loss per share from continuing operations, net income (loss) per share from discontinued operations and net income (loss) per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	65.28M	shares	2 Qtrs
Weighted-average number of common shares used in computing net loss per share from continuing operations, net income (loss) per share from discontinued operations and net income (loss) per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	68.78M	shares	2 Qtrs
Weighted-average number of common shares used in computing net loss per share from continuing operations, net income (loss) per share from discontinued operations and net income (loss) per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	68.96M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net income (loss) per share from discontinued operations and net income (loss) per share diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	61.07M	shares	1 Quarter

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-90.48M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-86.22M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$1.79B	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$1.87B	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-130.73M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-40.26M	USD	1 Quarter
Less: Net Income from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-8.98M	USD	1 Quarter
Less: Net Income from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-3.43M	USD	1 Quarter
Less: Net Income from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$34.85M	USD	2 Qtrs
Less: Net Income from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$1.96B	USD	2 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-173.67M	USD	2 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-165.59M	USD	2 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-82.79M	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-81.50M	USD	1 Quarter
Depreciation and amortization	`OtherDepreciationAndAmortization`	$4.89M	USD	2 Qtrs
Depreciation and amortization	`OtherDepreciationAndAmortization`	$4.83M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$33.28M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$29.74M	USD	2 Qtrs
Net amortization of premium (accretion of discount) on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-473.00K	USD	2 Qtrs
Net amortization of premium (accretion of discount) on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-3.42M	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-12.00K	USD	2 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortization`	$4.76M	USD	2 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortization`	$4.43M	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$8.13M	USD	2 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.29M	USD	2 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.45M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.56M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-5.56M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-8.27M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-2.55M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-4.15M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-3.63M	USD	2 Qtrs
Net cash used in operating activities - continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-159.23M	USD	2 Qtrs
Net cash used in operating activities - continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-136.19M	USD	2 Qtrs
Net cash used in operating activities - discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-36.96M	USD	2 Qtrs
Net cash used in operating activities - discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-78.81M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-173.16M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-238.04M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$189.60M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$498.90M	USD	2 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$273.15M	USD	2 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$328.88M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.26M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.34M	USD	2 Qtrs
Net cash (used in) provided by investing activities - continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-227.01M	USD	2 Qtrs
Net cash (used in) provided by investing activities - continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$130.94M	USD	2 Qtrs
Net cash provided by (used in) investing activities - discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$1.80B	USD	2 Qtrs
Net cash provided by (used in) investing activities - discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-348.00K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$130.59M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.58B	USD	2 Qtrs
Payments on financing lease obligations	`FinanceLeasePrincipalPayments`	$166.00K	USD	2 Qtrs
Payments on financing lease obligations	`FinanceLeasePrincipalPayments`	$170.00K	USD	2 Qtrs
Purchase of treasury stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Purchase of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$529.05M	USD	2 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$33.02M	USD	2 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$7.12M	USD	2 Qtrs
Net cash (used in) provided by financing activities - continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-496.20M	USD	2 Qtrs
Net cash (used in) provided by financing activities - continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$6.95M	USD	2 Qtrs
Net cash provided by financing activities - discontinued operations	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	2 Qtrs
Net cash provided by financing activities - discontinued operations	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	$250.54M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$257.49M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-496.20M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$214.93M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$841.69M	USD	2 Qtrs
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$127.44M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$80.93M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$295.86M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$969.12M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$127.44M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$80.93M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$295.86M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$969.12M	USD	Point-in-time
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$3.62M	USD	2 Qtrs
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$56.00K	USD	2 Qtrs
Operating lease liabilities arising from obtaining operating lease assets	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Operating lease liabilities arising from obtaining operating lease assets	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Financing lease liabilities arising from obtaining financing lease assets	`RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability`	-	USD	2 Qtrs
Financing lease liabilities arising from obtaining financing lease assets	`RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability`	$511.00K	USD	2 Qtrs

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$1.72B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$558.47M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$2.30B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$640.53M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$625.30M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$399.50M	USD	Point-in-time
Common stock issued under stock incentive plan and ESPP (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	677,154.00	shares	2 Qtrs
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.65M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$7.35M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.46M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$25.67M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.85M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.67M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.88M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.61M	USD	1 Quarter
Repurchase of common stock	`TreasuryStockValueAcquiredCostMethod`	$529.05M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.56M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-108.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-141.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-128.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-90.48M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-86.22M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$1.79B	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$1.87B	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-130.73M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-40.26M	USD	1 Quarter
Disposition of oncology business	`StockholdersEquityDispositionOfBusiness`	$-2.82M	USD	1 Quarter
Disposition of oncology business	`StockholdersEquityDispositionOfBusiness`	$-4.02M	USD	1 Quarter
Disposition of oncology business	`StockholdersEquityDispositionOfBusiness`	$-712.00K	USD	1 Quarter
Disposition of oncology business	`StockholdersEquityDispositionOfBusiness`	$-33.00K	USD	1 Quarter
Ending balance	`StockholdersEquity`	$1.72B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$558.47M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$2.30B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$640.53M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$625.30M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$399.50M	USD	Point-in-time

Comprehensive Income 14 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-90.48M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-86.22M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$1.79B	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$1.87B	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-130.73M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-40.26M	USD	1 Quarter
Unrealized (loss) gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-249.00K	USD	2 Qtrs
Unrealized (loss) gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.43M	USD	2 Qtrs
Unrealized (loss) gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.56M	USD	1 Quarter
Unrealized (loss) gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-141.00K	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-86.36M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-88.92M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$1.79B	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-129.30M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.